Cyient Semiconductors Secures 10M Equity Investment from Edelweiss at 500M Valuation OpenAIs Potential IPO Could Be Largest in History Challenging SpaceXs Lead SpaceX Launches Upgraded Starship V3 in 12th Test Flight Carrying Mock Starlink Satellites Bungie to End Destiny 2 Support Final Update Scheduled June 9 Game Remains Playable Brainbees Solutions Q4 Results Firstcry Parent Narrows Loss to Rs 30 Crore on 12 Revenue Growth Nostalgia and Speculation Fuel MultiMillion Dollar Pokmon Card Boom GNTX Q1 2026 Earnings EPS Beats Estimates by 38 Shares Edge Higher Everest Group Q1 2026 Earnings Strong EPS Beat Highlights Underwriting Strength HSBC Q1 2026 Earnings Modest EPS Beat Amid Quiet Trading Session UFPI Q1 2026 Earnings EPS Falls Short of Estimates Despite Positive Stock Reaction Cardiol Therapeutics CRDL Q4 2025 Earnings Narrower Loss Surpasses Estimates as PreRevenue Biotech Advances Pipeline EZPW Q1 2026 Earnings Strong EPS Surprise Driven by Operational Efficiencies Saul Centers Inc BFS Edges Higher as REIT Sector Stabilizes VisionWave Holdings VWAV Edges Lower Testing Key Support Zone Near 500 Kinross Gold KGC Stock Rises 352 as Gold Sector Gains Momentum James River Group Holdings JRVR Slides 27 as Market Pressures Weigh on Specially Insurer American Realty Investors ARL Declines Sharply Testing Key Support Zones Oil Prices Surge 3 as TrumpIran Tensions Escalate Strait of Hormuz Risk Premium Returns TSSI Q1 2026 Earnings Massive EPS Beat Fails to Lift Stock as Revenue Remains Undisclosed BlackRock TCP Capital TCPC Holds Near Support Amid Modest Decline AIRG Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction MSGE Q1 2026 Earnings EPS Falls Short of Estimates Stock Edges Higher Unity Software Q1 2026 Earnings Narrower Loss Beats Estimates Stock Edges Higher TBRG Q1 2026 Earnings EPS Misses Estimates Stock Edges Higher Despite Disappointing Quarter EPAM Systems Q1 2026 Earnings Solid EPS Beat Amid Cautious Demand Fortive Q1 2026 Earnings Strong EPS Beat Bolsters Investor Confidence ACTU Q1 2026 Earnings EPS Misses Estimates as Biotech Firm Continues RD Investment